Patent · US Active

Process for the preparation of a benzimidazole derivative

US8119810B2 · kind B2 · utility

6Cited by

0References

8Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Wolfgang Broeder · Heidesheim, DE
Rainer Sobotta · Ingelheim am Rhein, DE

Key dates

Filing date	Feb 5, 2008
Grant date	Feb 21, 2012
Priority date	—
Expiry date	Oct 8, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D401/12
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The invention relates to a process for preparing the compound of formula 1, a valuable intermediate product in the synthesis of the pharmaceutical active substance dabigatran etexilate.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.